Target intelligence / Profile preview

LON peptidase N-terminal domain and RING finger protein 2 (LONRF2)

Target
LONRF2
Molecular classification
Enzyme, Ubiquitin ligase, Peptidase
01

Overview

LON peptidase N-terminal domain and RING finger protein 2 (LONRF2) is a protein-coding gene in humans and other vertebrates encoding an enzyme that contains both a peptidase domain related to protein quality control and a RING finger domain implicated in ubiquitin ligase activity[2][4][8]. It is predicted to participate in the ubiquitination and degradation of misfolded or damaged proteins, contributing to cellular protein quality control pathways[2][5][8]. LONRF2 is localized to the cytoplasm and has been associated with ATP-dependent peptidase and ubiquitin protein ligase activities[2][5]. Disorders linked to LONRF2 include Immunodeficiency 15B and childhood germ cell cancer, though specific disease mechanisms have not yet been fully elucidated[2]. No approved drugs or strong biomarker roles have been identified for LONRF2, though its enzymatic function underlies potential therapeutic targeting in disease states characterized by protein misfolding or abnormal ubiquitination[2][5][8].

Other names
Lonrf2LONRF-22900060P06Rik (mouse)si:ch1073- (zebrafish)LON peptidase N-terminal domain and RING finger protein 2
02

Mechanism of action

Ubiquitin ligase activity (potential mechanism for any targeted therapeutic modulation); Proteostasis regulation

03

Biological functions

Protein quality controlUbiquitinationMisfolded protein bindingRibonucloprotein complex bindingATP-dependent peptidase activity
04

Disease associations

ImmunodeficiencyCancer

Beyond the preview

Go deeper on LON peptidase N-terminal domain and RING finger protein 2 (LONRF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LON peptidase N-terminal domain and RING finger protein 2 (LONRF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call